Is there an effective treatment for late-onset systemic lupus erythematosus?

dc.contributor.authorUgarte-Gil, M.F.es_ES
dc.contributor.authorAlarcón, G.S.es_ES
dc.date.accessioned6/22/2022 13:33
dc.date.accessioned2022-09-30T16:31:42Z
dc.date.available6/22/2022 13:33
dc.date.available2022-09-30T16:31:42Z
dc.date.issued2013
dc.description.abstractOver the past 60 years, overall mortality in systemic lupus erythematosus patients has dramatically decreased, but late mortality, which relates to the damage caused by the disease, its treatments and/or evolving comorbidities, is still high. This is particularly true in patients with late-onset lupus, a special subgroup of patients who, despite not having very active disease, experience a larger number of comorbidities, and higher damage accrual and mortality rates than early-onset patients. Treating these late-onset patients can be more difficult due to the risk of drug-drug interactions and aging-related processes. Antimalarials should be used whenever possible, and glucocorticoids and immunosuppressive drugs must used be carefully, especially in this population. NSAIDs should be avoided if possible. Adequate treatment of comorbidities should improve these patients' prognoses. © 2013 Future Medicine Ltd.es_ES
dc.formatapplication/pdfes_ES
dc.identifier.doi10.2217/ahe.13.36es_ES
dc.identifier.urihttps://doi.org/10.2217/ahe.13.36
dc.rightsinfo:eu-repo/semantics/closedAccesses_ES
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/es_ES
dc.sourceAging Healthes_ES
dc.subjectMedicinees_ES
dc.subject.ocdehttp://purl.org/pe-repo/ocde/ford#3.00.00es_ES
dc.titleIs there an effective treatment for late-onset systemic lupus erythematosus?es_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.type.versioninfo:eu-repo/semantics/publishedVersiones_ES
Archivos
Bloque original
Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
159. Is there an effective treatment for late-onset systemic lupus erythematosus.pdf
Tamaño:
560.63 KB
Formato:
Adobe Portable Document Format
Colecciones